Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Presentation entities : Altimmune, inc. save search
Altimmune Announces Presentation of Pemvidutide Clinical Data at Upcoming NASH-TAG Conference on January 6, 2024
Published: 2024-01-02 (Crawled : 13:30) - biospace.com/
ALT | $7.08 -6.47% -6.69% 12K
|
Commercial Services
|
| O: -1.07%
H: 0.63%
C: -5.48%
conference presentation
Altimmune to Present New Data on the Anti-Inflammatory and Anti-Fibrotic Properties of Pemvidutide in a Late-Breaking Presentation at The Liver Meeting® 2023
Published: 2023-10-25 (Crawled : 12:00) - globenewswire.com
ALT | $7.08 -6.47% -6.69% 12K
|
Commercial Services
|
| O: 2.12%
H: 1.45%
C: -1.66%
meeting liver presentation
Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at 59th Annual Meeting of the European Association for the Study of Diabetes
Published: 2023-09-26 (Crawled : 12:00) - globenewswire.com
ALT | $7.08 -6.47% -6.69% 12K
|
Commercial Services
|
| O: 0.0%
H: 6.38%
C: 0.4%
association presentation meeting diabetes study
Altimmune Announces Oral Presentation of Pemvidutide Clinical Data in Treatment of NAFLD at Upcoming EASL International Liver Congress™ 2023
Published: 2023-06-15 (Crawled : 12:00) - globenewswire.com
ALT | $7.08 -6.47% -6.69% 12K
|
Commercial Services
|
| O: 0.74%
H: 1.23%
C: 0.25%
liver presentation international treatment
Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at Upcoming NASH-TAG Conference on January 7, 2023
Published: 2023-01-04 (Crawled : 17:00) - biospace.com/
ALT | $7.08 -6.47% -6.69% 12K
|
Commercial Services
|
| O: 0.13%
H: 1.02%
C: -5.37%
conference presentation
Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at Upcoming EASL International Liver Congress™ on June 25, 2022Presentation to be highlighted in the Best of International Liver Congress
Published: 2022-06-17 (Crawled : 16:00) - biospace.com/
ALT | $7.08 -6.47% -6.69% 12K
|
Commercial Services
|
| O: -7.71%
H: 20.69%
C: 19.63%
liver presentation international
Altimmune Announces Oral Presentation of Pemvidutide Clinical Data at Upcoming EASL International Liver Congress™ on June 25, 2022
Published: 2022-06-17 (Crawled : 12:00) - globenewswire.com
ALT | $7.08 -6.47% -6.69% 12K
|
Commercial Services
|
| O: -7.71%
H: 20.69%
C: 19.63%
liver presentation international
Altimmune to Present at Upcoming Investor Conferences
Published: 2021-11-10 (Crawled : 00:00) - globenewswire.com
ALT | $7.08 -6.47% -6.69% 12K
|
Commercial Services
|
| O: -1.48%
H: 3.6%
C: 1.09%
conference presentation
Altimmune to Present at Upcoming Scientific Conferences
Published: 2021-04-29 (Crawled : 19:00) - biospace.com/
ALT | $7.08 -6.47% -6.69% 12K
|
Commercial Services
|
| O: 0.93%
H: 5.45%
C: 0.71%
conference presentation
Altimmune Partners with Summit Biosciences to Produce a Multidose Nasal Spray Presentation of its AdCOVID™ Vaccine CandidateMetered Multidose Device Allows for Convenient and Cost-effective Vaccination
Published: 2021-03-22 (Crawled : 12:00) - biospace.com/
ALT | $7.08 -6.47% -6.69% 12K
|
Commercial Services
|
| O: 0.61%
H: 2.06%
C: -4.12%
covid presentation nasal spray adcovid vaccine device
Altimmune to Present at Upcoming Conferences
Published: 2021-03-08 (Crawled : 00:01) - biospace.com/
ALT | $7.08 -6.47% -6.69% 12K
|
Commercial Services
|
| O: 0.93%
H: 8.5%
C: 0.23%
conference presentation
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
MTH | $154.69 -2.21% 7.56% 64
|
Consumer Durables
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
IHT P | $1.3712 0.82% 6.48% 0
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.